Qiagen Posts Double-Digit Growth in Q2 Revenues and Profit; Raises Full-Year Guidance | GenomeWeb
NEW YORK (GenomeWeb News) - Qiagen yesterday said second-quarter revenue rose 19 percent as R&D spending increased 25 percent and net income rose nearly 60 percent.
 
Financial results for the quarter did not include any contribution from Digene, which Qiagen purchased in a $1.6 billion deal that closed on July 31.
 
Total receipts for the three months ended June 30 rose to $135 million from $113.2 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.